Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population

Journal of the Neurological Sciences

Volumn 277, Issue 1-2, 2009, Pages 133-137

  Joshi, Gunjan ^a   Pradhan, S ^b   Mittal, B ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

Author keywords

Genetic polymorphism; Genetic susceptibility; Migraine; Multi factorial disorder

Indexed keywords

ACE ID GENE; ALLELE; ARTICLE; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INDIAN; LEUKOCYTE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE AURA; MTHFR GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MIGRAINE WITH AURA; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 58149459598     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.11.002     Document Type: Article

References (34)

1. Colson N.J., Lea R.A., Sharon Q., and Griffiths L.R. The role of vascular and hormonal genes in migraine susceptibility. Molec Genet Metab 88 2 (2006) 107-113
2. WHO. The World Health Report. Mental Health: New Understanding. New Hope (2001). http://www.who.int/whr2001/ http://www.who.int/whr2001/
3. Russell M.B., and Olesen J. The genetics of migraine without aura and migraine with aura. Cephalalgia 13 4 (1993) 245-248
4. Headache classification subcommittee of the international headache society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 24 (2004) 1-160 (suppl)
5. Moskowitz M.A. The neurobiology of vascular head pain. Ann Neurol 16 2 (1984) 157-168
6. Parsons A.A., and Strijbos P.J. The neuronal versus vascular hypothesis of migraine and cortical spreading depression. Curr Opin Pharmacol 3 3 (2003) 73-77
7. Montgomery L. Are angiotensin-converting enzyme (ACE) inhibitors effective in preventing migraine in nonhypertensive patients?. J Fam Pract 50 4 (2001) 299
8. Sharma P. Meta-analysis of the ACE gene in ischaemic stroke. J Neurol Neurosurg Psychiatry 64 2 (1998) 227-230
9. Pasha M.A., Khan A.P., Kumar R., Ram R.B., Grover S.K., Srivastava K.K., et al. Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins. J Biosci 27 (2002) 67-70 (1 Suppl.1)
10. Paterna S., Di Pasquale P., D A., Angelo, Seidita G., Tuttolomondo A., Cardinale A., et al. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 43 3 (2000) 133-136
11. Kowa H., Fusayasu E., Ijiri T., Ishizaki K., Yasui K., Nakaso K., et al. Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett 374 2 (2005) 129-131
12. Lea R.A., Ovcaric M., Sundholm J., Solyom L., MacMillan J., and Griffiths L.R. Genetic variants of angiotensin converting enzyme and methylene tetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res Mol Brain Res 136 1-2 (2005) 112-117
13. Kowa H., Shimomura T., and Takahashi K. Platelet gamma-aminobutyric acid levels in migraine and tension-type headache. Headache 32 5 (1992) 229-232
14. Tronvik E., Stovner L.J., Bovim G., White L.R., Gladwin A.J., Owen K., et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. BMC Neurol 8 (2008) 4
15. Colhoun H.M., McKeigue P.M., and Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 361 9360 (2003) 865-872
16. Lin J.J., Wang P.J., Chen C.H., Yueh K.C., Lin S.Z., and Harn H.J. Homozygous deletion deletion genotype of angiotensin converting enzyme confers protection against migraine in man. Acta Neurol Taiwan 14 3 (2005) 120-125
17. Kara I., Sazci A., Ergul E., Kaya G., and Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 111 1-2 (2003) 84-90
18. Oterino A., Valle N., Bravo Y., Munoz P., Sancez-Velasco P., Ruiz-Alegia C., et al. MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia 24 6 (2004) 491-494
19. Lea R.A., Ovcaric M., Sundholm J., MacMillan J., and Griffiths L.R. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med 12 (2004) 2-3
20. Rubino E., Ferrero M., Rainero I., Binello E., Vaula G., and Pinessi L. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis. Cephalalgia (2007) [Electronic publication ahead of print]
21. Kaunisto M.A., Kallela M., Hämäläinen E., Kilpikari R., Havanka H., Harno H., et al. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia 26 12 (2006) 1462-1472
22. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16 3 (1988) 1215
23. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F., et al. Evidence, from combined segregation and linkage analysis, that a variant of Angiotensin 1 converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51 1 (1992) 197-205
24. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 1 (1995) 111-113
25. Gauderman W.J. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155 5 (2002) 478-484
26. Munshi A., Sultana S., Kaul S., Reddy B.P., Alladi S., and Jyothy A. Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population. J Neurol Sci 272 1-2 (Sep 15 2008) 132-135
27. Mukherjee M., Joshi S., Bagadi S., Dalvi M., Rao A., and Shetty K.R. A low prevalence of the C677T mutation in methyleletetrahydrofolate reductase gene in Asian Indians. Clin Genet 61 2 (2002) 155-159
28. Guenther B.D., Sheppard C.A., Tran P., Rozen R., Matthews R.G., and Ludwig M.L. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol 6 4 (1999) 359-365
29. Scher A.I., Terwindt G.M., Verschuren W.M.M., Kruit M.C., Blom H.J., Kowa H., et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 59 2 (2006) 372-375
30. Li C., Zhang C., Qiu S., Lu X., Zeng Y., Wu H., et al. Polymorphisms of ACE-1 and MTHFR genes and genetic susceptibility of ischemic stroke. Zhonghua Yixue Zazhi 82 15 (2002) 1046-1049
31. Szolnoki Z., Somogyvári F., Kondacs A., Szabó M., and Fodor L. Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol 249 10 (2002) 1391-1397
32. Merikangas K.R., Fenton B.T., Cheng S.H., Stolar M.J., and Risch N. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 54 4 (1997) 362-368
33. Tzourio C., Iglesias S., Hubert J.B., Visy J.M., Alpérovitch A., Tehindrazanarivelo A., et al. Migraine and risk of ischaemic stroke: a case-control study. BMJ 307 6899 (1993) 289-292
34. Moskowitz M.A. Genes, proteases, cortical spreading depression and migraine: impact on pathophysiology and treatment. Funct Neurology 22 3 (2007) 133-136